Twin Presentations Position Merck, GSK PD-1 Inhibitors As Endometrial Cancer Rivals

 
• By Alaric DeArment
  
Merck presented data from a Phase III trial of Keytruda in endometrial cancer • Source: Shutterstock

More from Strategy

More from Business